In Vivo Microrobotic Sampling and Quantum Biosensing Closed Loops at the Limit A non-clinical architecture for observation action verification and safe refusal Core coupling Bounded in vivo sampling × quantum biosensing × closed-loop state decision Research scale 30 linked derivations × 82 chapters × 410 research sections × 200 detailed Research Gates Main result A testable pathway for deciding where, when, how strongly, and whether to sample again without allowing the observation process to silently manufacture the state estimate. Mother lineage Microrobotic Sampling and Quantum Biosensing Co-Design at the Limit Publication Abstract This monograph examines whether a microrobot can use an initial measurement to select a subsequent sampling location, time, volume, or sensing intensity while preserving the physiological state it claims to estimate. It treats the complete observation–action–state chain as the scientific object. Motion, signal amplitude, and controller accuracy are insufficient when sample identity, localization, disturbance, calibration, authorization, or uncertainty cannot be reconstructed. The architecture advances through phantoms, microfluidic challenge courses, organ-on-chip systems, authorized ex vivo tissue, and separately governed preclinical platforms. It makes no claim of present human deployment, diagnosis, treatment, dosing, or autonomous intervention. Its central falsifiable proposition is that, at matched disturbance, time, sample, and energy budgets, a bounded closed loop should provide more independently validated state information than fixed sampling. If the apparent gain is explained by additional measurements, hidden human correction, sample alteration, or untraceable calibration, the claim fails. Scientific Position and Hard Boundary The book starts from a strict distinction: observing a biological system is itself an intervention. A microrobot can redistribute analytes, perturb tissue, create heat, apply force, alter local flow, or change the timing of later observations. Quantum sensing can add sensitivity in selected settings, but it can also impose optical, thermal, magnetic, preparation, and readout costs. These effects are measured rather than hidden behind the labels minimally invasive or quantum enhanced. Candidate Research Expression Uloop = ΔIstate Psafe Ptrace − λs Dsample − λm Dmeasure − λo Roff-target • ΔIstate measures the reduction in uncertainty about the declared physiological state. • Psafe is the probability that actions remain inside the preregistered physical, biological, and authorization envelope. • Ptrace measures continuity of sample, location, time, device, sensor, calibration, model, and decision provenance. • Dsample and Dmeasure represent disturbance created by sampling and measurement. • Roff-target represents burden imposed on unintended tissue, samples, regions, or downstream decisions. Safety, authorization, irreversible harm, missing raw evidence, and invalid provenance remain hard vetoes. They cannot be cancelled by a favorable weighted score. Five-Layer Research Architecture 01 State and Claim Contract Define the physiological state, available actions, permitted use, disturbance limits, comparator, uncertainty, and conditions requiring abstention. 02 Transport Sampling and Interface Physics Quantify flow, diffusion, wall drag, contact, adsorption, shear, heat, fields, capture, release, recovery, and off-target burden. 03 Quantum and Classical Measurement Bind raw quantum observables and classical comparators to selectivity, calibration ancestry, uncertainty, drift, and measurement backaction. 04 Estimation Decision and Safe Control Use explicit belief states, expected information gain, partial observability, safe exploration, human override, and tiered authorization. 05 Test Ladder Transfer and Successor Choice Advance only through blinded testbeds, independent reproduction, fault injection, portability, creator-absent rebuild, and a real option to retire the system. Minimum Verifiable Prototype A blinded analyte gradient is embedded in an organ-on-chip testbed. Fixed sampling, expert-adjusted sampling, and a bounded autonomous closed loop receive matched time, energy, sample-volume, and disturbance budgets. The closed loop may choose the next location and measurement intensity only inside its registered safe action set. Independent assays reconstruct the hidden gradient and evaluate whether information gain remains after sample damage, localization error, sensor backaction, and extra sampling are accounted for. Research Contributions • Treats sampling as a state-changing intervention rather than a neutral collection step. • Connects microrobotic navigation, quantum measurement, state estimation, and safe control within one falsifiable chain. • Requires quantum channels to compete against fit-for-purpose classical sensors after preparation, readout, energy, and backaction costs are counted. • Maps thirty physically an
Abstract
In Vivo Microrobotic Sampling and Quantum Biosensing Closed Loops at the Limit A non-clinical architecture for observation action verification and safe refusal Core coupling Bounded in vivo sampling × quantum biosensing × closed-loop state decision Research scale 30 linked derivations × 82 chapters × 410 research sections × 200 detailed Research Gates Main result A testable pathway for deciding where, when, how strongly, and whether to sample again without allowing the observation process to silently manufacture the state estimate. Mother lineage Microrobotic Sampling and Quantum Biosensing Co-Design at the Limit Publication Abstract This monograph examines whether a microrobot can use an initial measurement to select a subsequent sampling location, time, volume, or sensing intensity while preserving the physiological state it claims to estimate. It treats the complete observation–action–state chain as the scientific object. Motion, signal amplitude, and controller accuracy are insufficient when sample identity, localization, disturbance, calibration, authorization, or uncertainty cannot be reconstructed. The architecture advances through phantoms, microfluidic challenge courses, organ-on-chip systems, authorized ex vivo tissue, and separately governed preclinical platforms. It makes no claim of present human deployment, diagnosis, treatment, dosing, or autonomous intervention. Its central falsifiable proposition is that, at matched disturbance, time, sample, and energy budgets, a bounded closed loop should provide more independently validated state information than fixed sampling. If the apparent gain is explained by additional measurements, hidden human correction, sample alteration, or untraceable calibration, the claim fails. Scientific Position and Hard Boundary The book starts from a strict distinction: observing a biological system is itself an intervention. A microrobot can redistribute analytes, perturb tissue, create heat, apply force, alter local flow, or change the timing of later observations. Quantum sensing can add sensitivity in selected settings, but it can also impose optical, thermal, magnetic, preparation, and readout costs. These effects are measured rather than hidden behind the labels minimally invasive or quantum enhanced. Candidate Research Expression Uloop = ΔIstate Psafe Ptrace − λs Dsample − λm Dmeasure − λo Roff-target • ΔIstate measures the reduction in uncertainty about the declared physiological state. • Psafe is the probability that actions remain inside the preregistered physical, biological, and authorization envelope. • Ptrace measures continuity of sample, location, time, device, sensor, calibration, model, and decision provenance. • Dsample and Dmeasure represent disturbance created by sampling and measurement. • Roff-target represents burden imposed on unintended tissue, samples, regions, or downstream decisions. Safety, authorization, irreversible harm, missing raw evidence, and invalid provenance remain hard vetoes. They cannot be cancelled by a favorable weighted score. Five-Layer Research Architecture 01 State and Claim Contract Define the physiological state, available actions, permitted use, disturbance limits, comparator, uncertainty, and conditions requiring abstention. 02 Transport Sampling and Interface Physics Quantify flow, diffusion, wall drag, contact, adsorption, shear, heat, fields, capture, release, recovery, and off-target burden. 03 Quantum and Classical Measurement Bind raw quantum observables and classical comparators to selectivity, calibration ancestry, uncertainty, drift, and measurement backaction. 04 Estimation Decision and Safe Control Use explicit belief states, expected information gain, partial observability, safe exploration, human override, and tiered authorization. 05 Test Ladder Transfer and Successor Choice Advance only through blinded testbeds, independent reproduction, fault injection, portability, creator-absent rebuild, and a real option to retire the system. Minimum Verifiable Prototype A blinded analyte gradient is embedded in an organ-on-chip testbed. Fixed sampling, expert-adjusted sampling, and a bounded autonomous closed loop receive matched time, energy, sample-volume, and disturbance budgets. The closed loop may choose the next location and measurement intensity only inside its registered safe action set. Independent assays reconstruct the hidden gradient and evaluate whether information gain remains after sample damage, localization error, sensor backaction, and extra sampling are accounted for. Research Contributions • Treats sampling as a state-changing intervention rather than a neutral collection step. • Connects microrobotic navigation, quantum measurement, state estimation, and safe control within one falsifiable chain. • Requires quantum channels to compete against fit-for-purpose classical sensors after preparation, readout, energy, and backaction costs are counted. • Maps thirty physically and statistically distinct derivations to specific chapter, experiment, and Research Gate corridors. • Provides eighty-two chapters with five research pages per chapter: boundary, mechanism, minimum experiment, adversarial validation, and successor route. • Turns two hundred Research Gates into complete future-study cards containing baseline, evidence, competing explanation, stop condition, next path, and handoff packet. • Preserves negative results and allows fixed sampling, conventional assays, or human control to remain the stronger answer. What the Book Does Not Claim The monograph does not report a completed human trial or establish that autonomous in-body sampling is currently safe or clinically effective. Organ-on-chip and ex vivo results cannot substitute for human evidence. Quantum sensitivity does not automatically imply diagnostic utility. Any translational program requires independent biological, engineering, ethical, regulatory, clinical, and post-market validation. Research Lineage and Selected DOI Ancestry Mother monograph and primary cross-link: https://doi.org/10.5281/zenodo.23318840 Medical microrobots review: https://doi.org/10.1146/annurev-bioeng-081523-033131 Motion control in magnetic microrobotics: https://doi.org/10.1146/annurev-control-032720-104318 Organ-on-chip proving grounds for microbiorobots: https://doi.org/10.3390/mi11100947 Vascularized organ-on-chip microrobot delivery: https://doi.org/10.1039/D3LC00770G Biologic tissue sampling with microgrippers: https://doi.org/10.1053/j.gastro.2013.01.066 Quantum sensing goes bio: https://doi.org/10.1038/s41578-022-00435-y Low-backaction chip-scale quantum measurement: https://doi.org/10.1103/PhysRevLett.126.090503 Nanodiamond optical-fiber quantum probe: https://doi.org/10.1021/acssensors.2c00670 Metrological traceability and measurement uncertainty: https://doi.org/10.11613/BM.2021.010501 Suggested English Description A high-density research monograph on bounded microrobotic sampling and quantum biosensing closed loops. The book develops thirty linked derivations, eighty-two chapters, five research sections per chapter, and two hundred detailed Research Gates. It asks whether a microrobot can decide where, when, how strongly, and whether to sample again while preserving the physiological state being estimated. The framework separates locomotion from autonomy, signal sensitivity from quantum advantage, and successful control from authorized and biologically safe action. It is intended as a non-clinical research architecture for microrobotics, biosensing, organ-on-chip validation, state estimation, metrology, safety engineering, and successor-governed scientific reconstruction. Keywords microrobotic sampling; quantum biosensing; closed-loop control; active sampling; organ-on-chip; state estimation; measurement backaction; biological disturbance; safe exploration; research gates; metrological traceability; successor governance IN VIVO MICROROBOTIC SAMPLING AND QUANTUM BIOSENSING CLOSED LOOPS
